Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) EPS (Weighted Average and Diluted): 2018-2024

Historic EPS (Weighted Average and Diluted) for Collegium Pharmaceutical (COLL) over the last 7 years, with Dec 2024 value amounting to $1.86.

  • Collegium Pharmaceutical's EPS (Weighted Average and Diluted) rose 211.11% to $0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.61, marking a year-over-year decrease of 30.60%. This contributed to the annual value of $1.86 for FY2024, which is 44.19% up from last year.
  • As of FY2024, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) stood at $1.86, which was up 44.19% from $1.29 recorded in FY2023.
  • Collegium Pharmaceutical's 5-year EPS (Weighted Average and Diluted) high stood at $1.86 for FY2021, and its period low was -$0.74 during FY2022.
  • For the 3-year period, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) averaged around $0.80, with its median value being $1.29 (2023).
  • As far as peak fluctuations go, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) plummeted by 139.78% in 2022, and later spiked by 274.32% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's EPS (Weighted Average and Diluted) (Yearly) stood at $0.76 in 2020, then spiked by 144.74% to $1.86 in 2021, then plummeted by 139.78% to -$0.74 in 2022, then spiked by 274.32% to $1.29 in 2023, then spiked by 44.19% to $1.86 in 2024.